Ilze Bāra

1.6k citations
16 papers · 1.1k · 2 hit papers · h-index 10

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Brain Metastases and Treatment
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • HER2/EGFR in Cancer Research

Papers in

Ilze Bāra

15 papers receiving 1.1k citations

Ilze Bāra's Hit Papers

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain 2021 · 231 citations
2310+1+3Years since publication50100150200

Peers

Ilze Bāra
Comparison fields: 5 of 52
  • Pulmonary and Respiratory Medicine 705
  • Oncology 382
  • Drug Discovery 2
  • Cancer Research 32
  • Otorhinolaryngology 8
Replace Mitsugu Kochi with:
Mitsugu Kochi Japan
Conrad R. Jacobs United States
Bo Jin China
Sang-Young Roh South Korea
Carlos Mayo United States
Federico Longo Muñoz Spain
Claudia-Nanette Gann Germany
Shruti Shally Saggi United States
Hidenobu Ishii Japan
Xinqun Chen China
Ilze Bāra relative to Mitsugu Kochi Japan Mitsugu Kochi's profile →
Citations per field
00.5×1.5×2×2.3×
Mitsugu Kochi · 1×
Citations per year

Countries citing papers authored by Ilze Bāra

Since Specialization
Citations

This map shows the geographic impact of Ilze Bāra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilze Bāra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilze Bāra more than expected).

Fields of papers citing papers by Ilze Bāra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilze Bāra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilze Bāra. The network helps show where Ilze Bāra may publish in the future.

Co-authors

The 25 scholars most cited alongside Ilze Bāra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ilze Bāra Line = papers co-authored together Ilze Bāra links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 2013256
2
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
Hit paper breakdown →
2021233
3
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
Hit paper breakdown →
2021231
4 2023134
5 201384
6 202352
7 201434
8 202024
9 202424
10 202311
11 20217
12 20237
13 20122
14 20142
15 20171
16 20260

About Ilze Bāra

Ilze Bāra is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Diagnosis and Treatment (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (705 citations), Oncology (382 citations), Drug Discovery (2 citations), Cancer Research (32 citations) and Otorhinolaryngology (8 citations). Ilze Bāra has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Federico Cappuzzo, Tony S.K. Mok, Barbara Klughammer, Wei Yu, Monika D. Kaul, Mark A. Socinski, Robert M. Jotte, Makoto Nishio, Gene Grant Finley and Martin Reck. Their work appears in journals such as Journal of Thoracic Oncology, Lung Cancer, Annals of Oncology, JAMA Oncology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact